.jpg?format=webp&width=780)
This pilot study aimed to assess the potential benefits of CCM in patients with HF with preserved left ventricular (LV) EF (HFpEF). This pilot study demonstrates that the benefits of CCM may extend to the HFpEF patient population. Furthermore, the significant improvement in health status observed, with no apparent impact on safety, suggests that utilization of CCM for patients with HFpEF could prove promising.
Like
Save
Share